{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:34:37Z","timestamp":1773272077096,"version":"3.50.1"},"reference-count":27,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/ol.2017.5661","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T08:13:02Z","timestamp":1485936782000},"page":"1595-1600","source":"Crossref","is-referenced-by-count":12,"title":["Association between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma"],"prefix":"10.3892","volume":"13","author":[{"given":"Hai-Zhen","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Lyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"key":"key20180108112446_b1-ol-0-0-5661","volume-title":"Cancer incidence in five continents","author":"Curado","year":"2007"},{"key":"key20180108112446_b2-ol-0-0-5661","volume-title":"World health organization classification of tumours: Pathology and genetics of tumours of the endocrine organs","author":"Lloyd","year":"2004"},{"key":"key20180108112446_b3-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1089\/thy.2004.14.1056","article-title":"Thyroid Cancer Committee: Increased incidence of thyroid carcinoma in france: A true epidemic or thyroid nodule management effects? Report from the French thyroid cancer committee","volume":"14","author":"Leenhardt","year":"2004","journal-title":"Thyroid"},{"key":"key20180108112446_b4-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/EJE-07-0896","article-title":"Thyroid papillary microcarcinoma: A descriptive and meta-analysis study","volume":"159","author":"Roti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key20180108112446_b5-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jso.20935","article-title":"Papillary thyroid microcarcinoma: Prognostic factors and treatment","volume":"97","author":"Besic","year":"2008","journal-title":"J Surg Oncol"},{"key":"key20180108112446_b6-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4158\/EP.13.5.498","article-title":"Management of low-risk differentiated thyroid cancer","volume":"13","author":"Mazzaferri","year":"2007","journal-title":"Endocr Pract"},{"key":"key20180108112446_b7-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1210\/jc.2005-0987","article-title":"BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer","volume":"90","author":"Xing","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108112446_b8-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/erc.1.0978","article-title":"BRAF mutation in thyroid cancer","volume":"12","author":"Xing","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"key20180108112446_b9-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/ERC-07-0212","article-title":"BRAF(V600E) mutation and the biology of papillary thyroid cancer","volume":"15","author":"Frasca","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"key20180108112446_b10-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1677\/ERC-07-0085","article-title":"New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy","volume":"14","author":"Riesco-Eizaguirre","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"key20180108112446_b11-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007","journal-title":"Endocr Rev"},{"key":"key20180108112446_b12-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1210\/jc.2006-1613","article-title":"BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells","volume":"92","author":"Liu","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108112446_b13-ol-0-0-5661","volume-title":"American joint committee of cancer, AJCC cancer staging manual","author":"AJCC","year":"2010","edition":"seventh"},{"key":"key20180108112446_b14-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1038\/srep09211","article-title":"Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay","volume":"5","author":"Qiu","year":"2015","journal-title":"Sci Rep"},{"key":"key20180108112446_b15-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1245\/s10434-012-2851-z","article-title":"Papillary microcarcinoma of the thyroid: Clinical characteristics and BRAF(V600E) mutational status of 977 cases","volume":"20","author":"Zheng","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"key20180108112446_b16-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1210\/jc.2011-3106","article-title":"A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome","volume":"97","author":"Guerra","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108112446_b17-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1089\/thy.2013.0036","article-title":"Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: A subgroup analysis of 3130 cases in a single center","volume":"23","author":"Lim","year":"2013","journal-title":"Thyroid"},{"key":"key20180108112446_b18-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00268-011-1383-1","article-title":"BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer","volume":"36","author":"Kim","year":"2012","journal-title":"World J Surg"},{"key":"key20180108112446_b19-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1245\/s10434-008-0233-3","article-title":"Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma","volume":"16","author":"Lee","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"key20180108112446_b20-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1477-7819-11-291","article-title":"The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors","volume":"11","author":"Choi","year":"2013","journal-title":"World J Surg Oncol"},{"key":"key20180108112446_b21-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/cncr.22754","article-title":"Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: A meta-analysis","volume":"110","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"key20180108112446_b22-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.humpath.2009.09.023","article-title":"Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant","volume":"42","author":"Smith","year":"2011","journal-title":"Hum Pathol"},{"key":"key20180108112446_b23-ol-0-0-5661","first-page":"794","article-title":"Correlation between BRAF V600E mutation and clinicopathologic features of papillary thyroid carcinoma","volume":"43","author":"Lu","year":"2014","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"key20180108112446_b24-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MD.0b013e31826a9c71","article-title":"BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: A systematic review and meta-analysis","volume":"91","author":"Tufano","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"key20180108112446_b25-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/ERC-13-0291","article-title":"Is BRAFV600E mutation a marker for central nodal metastasis in small papillary thyroid carcinoma?","volume":"21","author":"Lang","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"key20180108112446_b26-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/thy.2008.0144","article-title":"Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis","volume":"19","author":"Kim","year":"2009","journal-title":"Thyroid"},{"key":"key20180108112446_b27-ol-0-0-5661","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/cncr.26425","article-title":"A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma","volume":"118","author":"Niemeier","year":"2012","journal-title":"Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2017.5661\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T15:37:16Z","timestamp":1515425836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.5661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,2,1]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/ol.2017.5661"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.5661","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}